Gastritis denials in California external review

In the California DMHC record, independent physician reviewers decided 16 published external-review cases involving gastritisand overturned the plan’s denial in 37.5%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.

California DMHC decisions
16
2004–2023
Overturned
37.5%
6 denials reversed
Typical time to a decision
20 days
Most land between 18 and 21 days
Handled as urgent
18.8%
Expedited when a delay would cause harm

What the reviewers wrote

Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

The patient has requested authorization and coverage for acute hospitalization until a definitive diagnosis is determined; subacute hospitalization thereafter for the duration of recovery; one-on-one sitter to monitor risk of aspiration with oral suctioning; physical therapy; occupational therapy; speech therapy; a gastroenterology consultation/second opinion; neurology consultation/second opinion; an otolaryngology consultation/second opinion; a neuro-oncology consultation/second opinion; and/or a cardiology consultation. Based on the available documentation, this patient’s vomiting could be multifactorial due to her chronic medical conditions. The cause for her intractable vomiting has not been determined. The patient has been treated for gastroparesis with placement of a J-tube, consistent with the recommendations from the American College of Gastroenterology (ACG).
Medical Necessity · 2019 · IMR MN19-31761
Nature of Statutory Criteria/Case Summary: An enrollee has requested reimbursement for emergency medical services. Findings: The physician reviewer found that the patient presented to the emergency department with reports of abdominal pain located in the lower abdomen that began suddenly two days prior and had become persistent. Her symptoms commenced after eating pizza. She reported nausea, vomiting and low back pain. The patient’s past medical history included diabetes and hypercholesterolemia. Her vital signs showed a blood pressure of 122/69, temperature of 98.3 F and pulse of 72. Mild abdominal tenderness was present in all four quadrants with a positive Murphy’s sign. Laboratory data revealed ketonuria with a glucose of 144, but was unremarkable. An abdominal ultrasound was negative for gallstones or cholecystitis.
Urgent Care · 2017 · IMR UR17-26084

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
Nature of Statutory Criteria/Case Summary: The patient has requested reimbursement for monitored anesthesia care (MAC) services provided during an endoscope procedure. The current guidelines for sedation and anesthesia in gastrointestinal endoscopy concluded that that use of a “combination of an opioid and benzodiazepine is a safe and effective regimen for achieving minimal to moderate sedation for upper endoscopy and colonoscopy in patients without risk factors for sedation-related adverse events”. The guidelines further state that, “Minimal and/or moderate sedation can be delivered safely by endoscopists to patients who are ASA Class I, II, or III.
Medical Necessity · 2022 · IMR MN22-37259
Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization and coverage for wireless capsule endoscopy. On review of the available documentation, this patient presents with a history of abdominal pain, gastritis, and small sliding hiatal hernia. The patient’s provider has recommended valuation with wireless capsule endoscopy. As noted in the medical literature, wireless capsule endoscopy is recommended for the evaluation of patients for possible causes of small bowel bleeding, suspected Crohn’s disease, or abnormal small bowel imaging. One study noted that possible indications for small bowel capsule endoscopy include “obscure gastrointestinal bleeding, Crohn’s disease, small-intestinal polyps and tumors, and celiac disease”.
Experimental/Investigational · 2023 · IMR EI23-38760

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this condition generally, not any individual case.

How to use this in your appeal

These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving gastritis, then check the rights and deadlines that apply to your plan.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Fighting a denial for gastritis? Use the California record to prepare.

Explain my denial — freeStart my appeal · $9